E.U. Expands Antitrust Review Of Guidant Deal
As feared by industry observers, the European Commission chose Monday to expand its antitrust inquiry into the long-awaited acquisition of medical device maker Guidant Corp. by rival Boston Scientific Corp....To view the full article, register now.
Already a subscriber? Click here to view full article